Literature DB >> 20216335

Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Laura M Hodges1, Svetlana M Markova, Leslie W Chinn, Jason M Gow, Deanna L Kroetz, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20216335      PMCID: PMC3098758          DOI: 10.1097/FPC.0b013e3283385a1c

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  172 in total

1.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 2.  Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition.

Authors:  Surajit Dey
Journal:  Expert Opin Drug Deliv       Date:  2006-01       Impact factor: 6.648

3.  Differential phosphorylation patterns of P-glycoprotein reconstituted into a proteoliposome system: insight into additional unconventional phosphorylation sites.

Authors:  Isabelle H Lelong-Rebel; Carol O Cardarelli
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

4.  Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers.

Authors:  Geoffrey Mukwaya; Thomas MacGregor; David Hoelscher; Thomas Heming; Daniel Legg; Kelli Kavanaugh; Phillip Johnson; John P Sabo; Scott McCallister
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response.

Authors:  Chin-Chuan Hung; John Jen Tai; Chun-Jung Lin; Ming-Jen Lee; Horng-Huei Liou
Journal:  Pharmacogenomics       Date:  2005-06       Impact factor: 2.533

6.  Characterization of the human MDR1 gene.

Authors:  Miklos Bodor; Edward J Kelly; Rodney J Ho
Journal:  AAPS J       Date:  2005-02-16       Impact factor: 4.009

7.  Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability.

Authors:  Danxin Wang; Andrew D Johnson; Audrey C Papp; Deanna L Kroetz; Wolfgang Sadée
Journal:  Pharmacogenet Genomics       Date:  2005-10       Impact factor: 2.089

Review 8.  An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.

Authors:  Kohji Takara; Toshiyuki Sakaeda; Katsuhiko Okumura
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.

Authors:  Sonia Rodríguez Nóvoa; Pablo Barreiro; Ana Rendón; Ana Barrios; Angélica Corral; Inmaculada Jiménez-Nacher; Juan González-Lahoz; Vincent Soriano
Journal:  Clin Infect Dis       Date:  2005-12-08       Impact factor: 9.079

10.  Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.

Authors:  David W Haas; Laura M Smeaton; Robert W Shafer; Gregory K Robbins; Gene D Morse; Line Labbe; Grant R Wilkinson; David B Clifford; Richard T D'Aquila; Victor De Gruttola; Richard B Pollard; Thomas C Merigan; Martin S Hirsch; Alfred L George; John P Donahue; Richard B Kim
Journal:  J Infect Dis       Date:  2005-11-01       Impact factor: 5.226

View more
  129 in total

1.  Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation.

Authors:  Su-Fern Tan; Wendy Dunton; Xin Liu; Todd E Fox; Samy A F Morad; Dhimant Desai; Kenichiro Doi; Mark R Conaway; Shantu Amin; David F Claxton; Hong-Gang Wang; Mark Kester; Myles C Cabot; David J Feith; Thomas P Loughran
Journal:  J Lipid Res       Date:  2019-04-08       Impact factor: 5.922

2.  Pharmacogenomics and bioinformatics: PharmGKB.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

3.  Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment.

Authors:  Marzia Del Re; Tiziana Latiano; Leonardo Fidilio; Giuliana Restante; Franco Morelli; Evaristo Maiello; Romano Danesi
Journal:  EPMA J       Date:  2017-03-07       Impact factor: 6.543

Review 4.  Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

Authors:  Tristram A Lett; Henrik Walter; Eva J Brandl
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

5.  Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.

Authors:  Alma Faviola Favela-Mendoza; Héctor Rangel-Villalobos; Ingrid Fricke-Galindo; Alberto Ortega-Vázquez; Gabriela Martínez-Cortés; Marisol López-López
Journal:  Mol Biol Rep       Date:  2018-10-13       Impact factor: 2.316

Review 6.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

7.  CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.

Authors:  Sze Wa Chan; Miao Hu; Sara Shun Wah Ko; Catherine Wing Yan Tam; Benny Siu Pong Fok; Ophelia Qi Ping Yin; Moses Sing Sum Chow; Brian Tomlinson
Journal:  Eur J Clin Pharmacol       Date:  2012-10-23       Impact factor: 2.953

8.  Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics.

Authors:  S Sadhasivam; V Chidambaran; X Zhang; J Meller; H Esslinger; K Zhang; L J Martin; J McAuliffe
Journal:  Pharmacogenomics J       Date:  2014-10-14       Impact factor: 3.550

9.  Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.

Authors:  Muriel Noetzli; Monia Guidi; Karsten Ebbing; Stephan Eyer; Laurence Wilhelm; Agnès Michon; Valérie Thomazic; Ioana Stancu; Abdel-Messieh Alnawaqil; Christophe Bula; Serge Zumbach; Michel Gaillard; Panteleimon Giannakopoulos; Armin von Gunten; Chantal Csajka; Chin B Eap
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

Review 10.  ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.

Authors:  Pérez-De Marcos Juan-Carlos; Pérez-Pineda Perla-Lidia; Méndez-Morales Stephanie-Talia; Arellano-Mendoza Mónica-Griselda; Torres-Espíndola Luz-María
Journal:  Mol Biol Rep       Date:  2021-02-22       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.